Not Signed In - Trying To Improve On Activity Of Interferon-Alpha In Metastatic Renal Cell Carcinoma: Interferon Plus Cimetidine In A Phase III Randomized Trial
Mon, 21 Aug 2006 07:00 AM EST
... UroToday.com - Interferon-alpha (IFN) has been a mainstay in the systemic treatment of metastatic renal cell carcinoma (RCC) for decades, with response rates ranging from 3-15%. Unlike interleukin 2, it has shown a survival benefit for patients in phase III randomized trials. [click link for full article] ...
Related Topics
- Clinical Trials
- Cimetidine
- Antithrombin III
- Familial Dysautonomia
- Ribavirin and Interferon alfa-2b, recombinant
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Interferon Alfa-2a
- Interferon Alfa-2b
- Interferon
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - compression type
- Cranial mononeuropathy III - diabetic type
- Antithrombin
- Interferon Gamma-1b Injection
- Interferon alfa n3 Injection
- Interferon Alfacon-1 Injection
- Interferon alfa-n1
- Cimetidine Liquid
- Cimetidine Injection
email this page
print this page
bookmark this page
feedback on this page
